4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-23-006327
Chief Operating Officer sold 23,684 shares at an average $8.59 ($203,487)
- Chief Operating Officer acquired 88,652 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
ADAMS R MARK · Chief Operating Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-06 | Grant or award : show line 1 in the form | +88,652 | 202,170 | D | ||
| 2023-03-06 | Sale : show line 2 in the form | −6,529 | $8.57 | $55,954 | 195,641 | D |
| 2023-03-07 | Sale : show line 3 in the form | −17,155 | $8.60 | $147,533 | 178,486 | D |
| Open-market sales · 23,684 sh · avg $8.59 · $203,487 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-06 | Grant or award : show line 4 in the form Stock Option (right to buy) | +133,033 | 133,033 | D |
Loading xslF345X03/form4.xml…